PLMA_1170x120_5-28-21

Katy Rauen

Drug chains can ward off new digital Rx players

Drug chains can ward off new digital Rx players

The U.S. prescription drug market has reached half a trillion dollars, much of it dominated by large pharmacy service providers. But with a pie this big, it’s little wonder that new players are looking to horn in on the action — in particular “digital native” start-ups that give customers the direct consumer-centric relationship and flexible

M&A activity heats up in specialty pharmacy

M&A activity heats up in specialty pharmacy

In recent years, the specialty pharmacy industry has been defined by rapid growth with considerable entry from new participants. Factors driving growth include an increase of therapies introduced into the pharmacy benefit class rather than through the medical benefit, a growing number of patients receiving treatment for a wider range of conditions, price inflation caused